Epidermal Growth Factor Receptor (EGFR) inhibitors are effective treatments for certain cancers, such as lung and colorectal cancer. However, they frequently cause skin-related side effects that can impact patient quality of life and adherence to treatment. Anisha Patel, M.D., and Christine Parseghian, M.D., discuss why these skin side effects occur, introduce a potential new treatment option, and share practical tips to help patients manage them.
